Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Willis Towers Watson (WTW)

WTW posts $88 million full-year GAAP loss on over $1.0 billion TRANZACT sale impairment

Mixed Impact 4 of 5 earnings Written later

WTW reported fourth-quarter and full-year 2024 results. Revenue rose 5% to $9.9 billion for the year and adjusted diluted EPS rose 17% to $16.93, but the company swung to a GAAP net loss of $88 million, driven mainly by impairment charges of over $1.0 billion tied to the sale of TRANZACT. The filing also gives 2025 expectations, including about $1.5 billion of planned share repurchases.

Key points

  • Full-year 2024 revenue was $9.93 billion, up 5%; organic revenue growth was 5%.
  • Full-year diluted loss per share was $0.96, versus diluted EPS of $9.95 in 2023, mainly due to impairment charges of over $1.0 billion related to the TRANZACT sale.
  • Full-year adjusted diluted EPS was $16.93, up 17% from $14.49.
  • Fourth-quarter diluted EPS was $12.25, up 105%; adjusted diluted EPS was $8.13, up 9%.

The filing

CompanyWillis Towers Watson (WTW)
Form8-K, current report
Filed with the SECFeb 4, 2025, 6:00 AM ET
Accession number0001171843-25-000589

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.